While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be ...
"I don't think we needed this crazy journey," the "SNL" alum says of the tumultuous lead-up to the film's long-delayed ...
Opinion
The Nation on MSNOpinion

An Unlawful War

The precedent being set by the US in launching this war of aggression against Iran will long live in infamy. Richard Falk On February 28, Trump embarked on a war against Iran, deliberately targeting ...
UniQure needs to run another trial to prove its gene therapy "actually helps people with Huntington's disease," said a senior FDA official.
Will Forte, who played MacGruber on Saturday Night Live, and his brother-in-law Doug Modling, who has Huntington's Disease, ...
SAN FRANCISCO, CA AND NEW YORK, NY / ACCESS Newswire / February 24, 2026 / Unlearn, a leading artificial intelligence company in the clinical development space, today announced its use of data from ...
Neuroscience rarely enjoys clean experiments. Most brain disorders are mosaics of risk genes, aging, lifestyle and chance that leave their origins obscured. Huntington's disease (HD) is different. It ...
The return of Paradise Season 2 features a number of new episodes containing a set of new questions about the overall storyline, and one of which many viewers are curious about is regarding what part, ...
Actor-comedian Will Forte has a brother-in-law, Doug, with Huntington’s Disease (HD), and they’re both now starring in an awareness campaign about the rare neurological disease from Teva ...
NEW YORK, March 4 (Reuters) - UniQure's trial design for its gene therapy for Huntington's disease did not offer sufficient proof that the drug slowed disease progression, a top U.S. Food and Drug ...
UniQure said Monday that plans to seek approval for its Huntington’s disease treatment with the Food and Drug Administration ...
Uniqure NV is the latest firm to get caught between the FDA’s shifting demands for “gold standard” science and regulatory flexibility for rare disease therapies. The company disclosed in its latest ...